PTEN as a tumor suppressor, negatively regulating AKT/PKB signaling pathway by preferentially dephosphorylates phosphoinositide substrates, is mutated in a large number of cancers including 40-50% of human liver cancers such as HCC and cholangiocarcinoma [22]. The gene discussed is AKT1; the disease is hepatocellular carcinoma.